By Allison Prang

 

The U.S. Food and Drug Administration approved Gilead Sciences Inc.'s remdesivir treatment -- known as Veklury-- for people that need to be hospitalized from Covid-19, the company said Thursday.

The drug had been approved by the regulator for emergency use to treat people who got the virus. In one trial of the treatment, it was shown to improve recovery time by five days when looking at the total study population, according to Gilead.

 

Write to Allison Prang at allison.prang@wsj.com

(END) Dow Jones Newswires

October 22, 2020 16:46 ET (20:46 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Nov 2020 to Dec 2020 Click Here for more Gilead Sciences Charts.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Dec 2019 to Dec 2020 Click Here for more Gilead Sciences Charts.